INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹163 Cr | ₹164 Cr | ₹89 Cr | ₹60 Cr | ₹56 Cr |
What is the latest Contingent Liabilities ratio of INDOCO REMEDIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹163 Cr |
| Mar2024 | ₹164 Cr |
| Mar2023 | ₹89 Cr |
| Mar2022 | ₹60 Cr |
| Mar2021 | ₹56 Cr |
How is Contingent Liabilities of INDOCO REMEDIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹163 Cr | -0.60 | |
| Mar2024 | ₹164 Cr | 83.75 | |
| Mar2023 | ₹89 Cr | 48.09 | |
| Mar2022 | ₹60 Cr | 7.79 | |
| Mar2021 | ₹56 Cr | - | |
Compare Contingent Liabilities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹1,788.8 Cr | 17.6% | -1.9% | -18.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,326.0 Cr | -2.2% | -1.8% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,282.0 Cr | -1.6% | -7.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,043.0 Cr | -4.1% | -6.7% | 23.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,854.2 Cr | -4.7% | -7.3% | 6.4% | Stock Analytics | |
| CIPLA | ₹97,115.7 Cr | -1.7% | -8.4% | -16.7% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 17.6% |
-1.9% |
-18.6% |
| SENSEX | 1.4% |
-7% |
-3.9% |
You may also like the below Video Courses